NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Non-alcoholic fatty liver disease (NAFLD) is a public health problem, affecting up to a third of
the world's adult population. Several cohort studies have consistently documented that …
the world's adult population. Several cohort studies have consistently documented that …
The relationship between type 2 diabetes, NAFLD, and cardiovascular risk
C Caussy, A Aubin, R Loomba - Current diabetes reports, 2021 - Springer
Abstract Purpose of Review Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
mellitus (T2DM) are strongly associated. Both also associate with an increased risk of …
mellitus (T2DM) are strongly associated. Both also associate with an increased risk of …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
XD Zhou, G Targher, CD Byrne, V Somers… - Hepatology …, 2023 - Springer
Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …
increasingly common condition with a global prevalence of~ 25–30% and is also associated …
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both
manifestations of end-organ damage of the metabolic syndrome. Through multiple …
manifestations of end-organ damage of the metabolic syndrome. Through multiple …
Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors
The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising. NAFLD/nonalcoholic
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …
A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease
JZK Toh, XH Pan, PWL Tay, CH Ng, JN Yong… - Clinical …, 2022 - Elsevier
Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Background and aim Non-alcoholic fatty liver disease (NAFLD), affecting up to around 30%
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …
Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
K Drożdż, K Nabrdalik, H Kwiendacz, M Hendel… - Cardiovascular …, 2022 - Springer
Background Nonalcoholic fatty liver disease is associated with an increased cardiovascular
disease (CVD) risk, although the exact mechanism (s) are less clear. Moreover, the …
disease (CVD) risk, although the exact mechanism (s) are less clear. Moreover, the …
Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: Associations with fructose metabolism and gut microbiota
K Drożdż, K Nabrdalik, W Hajzler, H Kwiendacz… - Nutrients, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition associated
with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Since systemic metabolic …
with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Since systemic metabolic …